<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font29 { font-size : 29; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">[]. </span>
   <span class="font29">COVID- </span>
   <span class="font21">patients </span>
   <span class="font20">treatment </span>
   <span class="font19">viral </span>
   <span class="font18">virus </span>
   <span class="font17">SARS-CoV- </span>
   <span class="font17">coronavirus </span>
   <span class="font17">clinical </span>
   <span class="font16">efficacy </span>
   <span class="font16">NCT </span>
   <span class="font15">drug </span>
   <span class="font15">cell </span>
   <span class="font14">safety </span>
   <span class="font14">study </span>
   <span class="font14">activity </span>
   <span class="font14">antiviral </span>
   <span class="font14">RNA </span>
   <span class="font14">combination </span>
   <span class="font14">host </span>
   <span class="font14">protein </span>
   <span class="font14">treat </span>
   <span class="font14">respiratory </span>
   <span class="font13">novel </span>
   <span class="font13">trial </span>
   <span class="font13">SARS </span>
   <span class="font13">pneumonia </span>
   <span class="font13">Oral </span>
   <span class="font13">drugs </span>
   <span class="font13">route </span>
   <span class="font13">infection </span>
   <span class="font13">trials </span>
   <span class="font13">replication </span>
   <span class="font13">severe </span>
   <span class="font13">(n.d.). </span>
   <span class="font13">evaluate </span>
   <span class="font12">(accessed </span>
   <span class="font12">SARS-CoV </span>
   <span class="font12">University </span>
   <span class="font12">spike </span>
   <span class="font12">treating </span>
   <span class="font12">China </span>
   <span class="font12">disease </span>
   <span class="font12">therapy </span>
   <span class="font12">cells </span>
   <span class="font12">COVID-. </span>
   <span class="font12">therapeutic </span>
   <span class="font12">use </span>
   <span class="font12">hydroxychloroquine </span>
   <span class="font12">inhibits </span>
   <span class="font12">{border-style </span>
   <span class="font12">like </span>
   <span class="font12">protease </span>
   <span class="font12">results </span>
   <span class="font12">showed </span>
   <span class="font12">... </span>
   <span class="font12">ACE- </span>
   <span class="font12">Medical </span>
   <span class="font12">RBV </span>
   <span class="font12">United </span>
   <span class="font12">complex </span>
   <span class="font12">plasma </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">ARB </span>
   <span class="font12">COVID-, </span>
   <span class="font12">MERS-CoV </span>
   <span class="font12">cases </span>
   <span class="font12">https://clinicaltrials.gov/ct/show/NCT </span>
   <span class="font12">human </span>
   <span class="font12">membrane </span>
   <span class="font12">potential </span>
   <span class="font12">proteins </span>
   <span class="font12">repurposing </span>
   <span class="font11">April </span>
   <span class="font11">Clinical </span>
   <span class="font11">ClinicalTrials.gov, </span>
   <span class="font11">NCT, </span>
   <span class="font11">Research </span>
   <span class="font11">immune </span>
   <span class="font11">receptor </span>
   <span class="font11">receptors </span>
   <span class="font11">syndrome </span>
   <span class="font11">text </span>
   <span class="font11">view </span>
   <span class="font11">RDV </span>
   <span class="font11">approved </span>
   <span class="font11">vaccines </span>
   <span class="font11">[], </span>
   <span class="font11">binding </span>
   <span class="font11">genome </span>
   <span class="font11">initiated </span>
   <span class="font11">lung </span>
   <span class="font11">polymerase </span>
   <span class="font11">randomized, </span>
   <span class="font11">research </span>
   <span class="font11">shown </span>
   <span class="font11">effect </span>
   <span class="font11">effective </span>
   <span class="font11">effects </span>
   <span class="font11">entry </span>
   <span class="font11">fusion </span>
   <span class="font11">influenza </span>
   <span class="font11">inhibitors </span>
   <span class="font11">new </span>
   <span class="font11">reported </span>
   <span class="font11">used </span>
   <span class="font11">virus, </span>
   <span class="font11">viruses </span>
   <span class="font11">vitro </span>
   <span class="font11">ChiCTR, </span>
   <span class="font11">Drug </span>
   <span class="font11">Hydroxychloroquine </span>
   <span class="font11">I.V </span>
   <span class="font11">MERS </span>
   <span class="font11">action </span>
   <span class="font11">caused </span>
   <span class="font11">chloroquine </span>
   <span class="font11">current </span>
   <span class="font11">cytokine </span>
   <span class="font11">oral </span>
   <span class="font11">Fig. </span>
   <span class="font11">Health </span>
   <span class="font11">However, </span>
   <span class="font11">INF </span>
   <span class="font11">States </span>
   <span class="font11">[,]. </span>
   <span class="font11">acute </span>
   <span class="font11">control </span>
   <span class="font11">data </span>
   <span class="font11">days </span>
   <span class="font11">development </span>
   <span class="font11">dose </span>
   <span class="font11">form </span>
   <span class="font11">given </span>
   <span class="font11">hospitalized </span>
   <span class="font11">infected </span>
   <span class="font11">inhibiting </span>
   <span class="font11">levels </span>
   <span class="font11">main </span>
   <span class="font11">mechanism </span>
   <span class="font11">open </span>
   <span class="font11">pandemic </span>
   <span class="font11">present </span>
   <span class="font11">storm </span>
   <span class="font11">CoVs </span>
   <span class="font11">FPV </span>
   <span class="font11">Plus </span>
   <span class="font11">TCZ </span>
   <span class="font11">ability </span>
   <span class="font11">adverse </span>
   <span class="font11">analysis </span>
   <span class="font11">assess </span>
   <span class="font11">associated </span>
   <span class="font11">based </span>
   <span class="font11">broad-spectrum </span>
   <span class="font11">concentration </span>
   <span class="font11">domain </span>
   <span class="font11">interferon </span>
   <span class="font11">load </span>
   <span class="font11">mainly </span>
   <span class="font11">prevent </span>
   <span class="font11">production </span>
   <span class="font11">structure </span>
   <span class="font11">transmission </span>
   <span class="font11">â€"Â </span>
   <span class="font11">-nCoV </span>
   <span class="font11">FDA </span>
   <span class="font11">Hospital, </span>
   <span class="font11">Oseltamivir </span>
   <span class="font11">Wuhan, </span>
   <span class="font11">cytokines </span>
   <span class="font11">demonstrated </span>
   <span class="font11">inhibition </span>
   <span class="font11">recent </span>
   <span class="font11">reduce </span>
   <span class="font11">studies </span>
   <span class="font11">various </span>
   <span class="font11">â€" </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">Infect. </span>
   <span class="font10">National </span>
   <span class="font10">Teicoplanin </span>
   <span class="font10">acts </span>
   <span class="font10">aim </span>
   <span class="font10">amino </span>
   <span class="font10">available </span>
   <span class="font10">azithromycin </span>
   <span class="font10">bacterial </span>
   <span class="font10">baricitinib </span>
   <span class="font10">binds </span>
   <span class="font10">controlled </span>
   <span class="font10">convalescent </span>
   <span class="font10">function </span>
   <span class="font10">group </span>
   <span class="font10">half-life </span>
   <span class="font10">identified </span>
   <span class="font10">inhibit </span>
   <span class="font10">injection </span>
   <span class="font10">low </span>
   <span class="font10">metabolized </span>
   <span class="font10">metal </span>
   <span class="font10">phase </span>
   <span class="font10">possible </span>
   <span class="font10">process </span>
   <span class="font10">promising </span>
   <span class="font10">px; </span>
   <span class="font10">randomized </span>
   <span class="font10">reducing </span>
   <span class="font10">replication. </span>
   <span class="font10">role </span>
   <span class="font10">structural </span>
   <span class="font10">targets </span>
   <span class="font10">virus. </span>
   <span class="font10">{font-family </span>
   <span class="font10">â€² </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Fellowship </span>
   <span class="font10">HCQ </span>
   <span class="font10">HIV </span>
   <span class="font10">Hospital </span>
   <span class="font10">Med. </span>
   <span class="font10">New </span>
   <span class="font10">Rev. </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV. </span>
   <span class="font10">acid </span>
   <span class="font10">agents </span>
   <span class="font10">anti-viral </span>
   <span class="font10">block </span>
   <span class="font10">cellular </span>
   <span class="font10">clinicaltrials.govhttps://clinicaltrials.gov/ct/show/NCT </span>
   <span class="font10">cyclosporine </span>
   <span class="font10">effectiveness </span>
   <span class="font10">endocytosis </span>
   <span class="font10">enzyme </span>
   <span class="font10">font-size </span>
   <span class="font10">genomic </span>
   <span class="font10">hepatitis </span>
   <span class="font10">including </span>
   <span class="font10">increase </span>
   <span class="font10">infections </span>
   <span class="font10">inflammatory </span>
   <span class="font10">involved </span>
   <span class="font10">kinase </span>
   <span class="font10">known </span>
   <span class="font10">leads </span>
   <span class="font10">life </span>
   <span class="font10">liver </span>
   <span class="font10">mild </span>
   <span class="font10">moderate </span>
   <span class="font10">number </span>
   <span class="font10">open-label </span>
   <span class="font10">pathway </span>
   <span class="font10">pathways </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">potent </span>
   <span class="font10">preventing </span>
   <span class="font10">repurposed </span>
   <span class="font10">ribavirin </span>
   <span class="font10">ritonavir </span>
   <span class="font10">sirolimus </span>
   <span class="font10">site </span>
   <span class="font10">surface </span>
   <span class="font10">test </span>
   <span class="font10">time </span>
   <span class="font10">transcription </span>
   <span class="font10">using </span>
   <span class="font10">(for </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Cell </span>
   <span class="font10">Center, </span>
   <span class="font10">China, </span>
   <span class="font10">Chinese </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">East </span>
   <span class="font10">Ebola </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">IL- </span>
   <span class="font10">Institute, </span>
   <span class="font10">LPV </span>
   <span class="font10">Phase </span>
   <span class="font10">RTV </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">administration </span>
   <span class="font10">agent </span>
   <span class="font10">antibodies </span>
   <span class="font10">bioavailability </span>
   <span class="font10">blocks </span>
   <span class="font10">case </span>
   <span class="font10">cleavage </span>
   <span class="font10">considered </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">countries </span>
   <span class="font10">currently </span>
   <span class="font10">decrease </span>
   <span class="font10">dependent </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">effectively </span>
   <span class="font10">efficiently </span>
   <span class="font10">enzymes </span>
   <span class="font10">epithelial </span>
   <span class="font10">family </span>
   <span class="font10">genetic </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">inhibitory </span>
   <span class="font10">interaction </span>
   <span class="font10">ions </span>
   <span class="font10">ivermectin </span>
   <span class="font10">leading </span>
   <span class="font10">major </span>
   <span class="font10">mediated </span>
   <span class="font10">multiple </span>
   <span class="font10">outbreak </span>
   <span class="font10">properties </span>
   <span class="font10">proteases </span>
   <span class="font10">rapid </span>
   <span class="font10">release </span>
   <span class="font10">required </span>
   <span class="font10">similar </span>
   <span class="font10">strategies </span>
   <span class="font10">suspected </span>
   <span class="font10">synthesis </span>
   <span class="font10">teicoplanin </span>
   <span class="font10">tissue </span>
   <span class="font10">vaccine </span>
   <span class="font10">world </span>
   <span class="font10">Acad. </span>
   <span class="font10">Agents </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">COVD- </span>
   <span class="font10">Care </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">CoV </span>
   <span class="font10">Dr. </span>
   <span class="font10">Elsevier </span>
   <span class="font10">India </span>
   <span class="font10">Manipal </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Rev </span>
   <span class="font10">Spike </span>
   <span class="font10">States, </span>
   <span class="font10">Study </span>
   <span class="font10">Table </span>
   <span class="font10">Treatment </span>
   <span class="font10">University, </span>
   <span class="font10">Versus </span>
   <span class="font10">[[], </span>
   <span class="font10">[]]. </span>
   <span class="font10">adenosine </span>
   <span class="font10">antibiotic </span>
   <span class="font10">arbidol </span>
   <span class="font10">bat </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bound </span>
   <span class="font10">cause </span>
   <span class="font10">compounds </span>
   <span class="font10">conditions </span>
   <span class="font10">conducted </span>
   <span class="font10">cycle </span>
   <span class="font10">day </span>
   <span class="font10">decreasing </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">developing </span>
   <span class="font10">dimer </span>
   <span class="font10">double </span>
   <span class="font10">elevated </span>
   <span class="font10">emerging </span>
   <span class="font10">forms </span>
   <span class="font10">highly </span>
   <span class="font10">hospitalization </span>
   <span class="font10">humans </span>
   <span class="font10">important </span>
   <span class="font10">include </span>
   <span class="font10">increased </span>
   <span class="font10">induced </span>
   <span class="font10">inflammation </span>
   <span class="font10">infusion </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">initiated. </span>
   <span class="font10">internalization </span>
   <span class="font10">intracellular </span>
   <span class="font10">investigational </span>
   <span class="font10">lipid </span>
   <span class="font10">maximum </span>
   <span class="font10">molecular </span>
   <span class="font10">mortality </span>
   <span class="font10">obtained </span>
   <span class="font10">ongoing </span>
   <span class="font10">outcomes </span>
   <span class="font10">positive </span>
   <span class="font10">preclinical </span>
   <span class="font10">prevents </span>
   <span class="font10">profile </span>
   <span class="font10">progress </span>
   <span class="font10">proteins, </span>
   <span class="font10">recently </span>
   <span class="font10">related </span>
   <span class="font10">resulting </span>
   <span class="font10">review </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">started </span>
   <span class="font10">strategy </span>
   <span class="font10">suppressing </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">therapeutics </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">tract </span>
   <span class="font10">vaccines, </span>
   <span class="font10">vital </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(NCT) </span>
   <span class="font10">Acute </span>
   <span class="font10">Cancer </span>
   <span class="font10">Centre </span>
   <span class="font10">Cyclosporine </span>
   <span class="font10">DNA </span>
   <span class="font10">DRV </span>
   <span class="font10">Delhi </span>
   <span class="font10">France </span>
   <span class="font10">GS- </span>
   <span class="font10">Government </span>
   <span class="font10">India, </span>
   <span class="font10">Institute </span>
   <span class="font10">Interferon </span>
   <span class="font10">International </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">Middle </span>
   <span class="font10">Natl. </span>
   <span class="font10">Patients </span>
   <span class="font10">Pegylated </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">S.C </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Sci. </span>
   <span class="font10">Sciences, </span>
   <span class="font10">Severe </span>
   <span class="font10">Spain </span>
   <span class="font10">Syndrome </span>
   <span class="font10">Virus </span>
   <span class="font10">Wuhan </span>
   <span class="font10">absorbed </span>
   <span class="font10">accessory </span>
   <span class="font10">administered </span>
   <span class="font10">adults </span>
   <span class="font10">affected </span>
   <span class="font10">affinity </span>
   <span class="font10">animal </span>
   <span class="font10">antibiotics </span>
   <span class="font10">belong </span>
   <span class="font10">better </span>
   <span class="font10">blocking </span>
   <span class="font10">bold </span>
   <span class="font10">candidates </span>
   <span class="font10">care </span>
   <span class="font10">carried </span>
   <span class="font10">centre </span>
   <span class="font10">changes </span>
   <span class="font10">chronic </span>
   <span class="font10">class </span>
   <span class="font10">clinically </span>
   <span class="font10">combating </span>
   <span class="font10">components </span>
   <span class="font10">condition </span>
   <span class="font10">corona </span>
   <span class="font10">corticosteroid </span>
   <span class="font10">courier; </span>
   <span class="font10">death </span>
   <span class="font10">design </span>
   <span class="font10">distribution </span>
   <span class="font10">dromedary </span>
   <span class="font10">em; </span>
   <span class="font10">enter </span>
   <span class="font10">epidemic </span>
   <span class="font10">expected </span>
   <span class="font10">failure </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">formation </span>
   <span class="font10">future </span>
   <span class="font10">having </span>
   <span class="font10">helicase </span>
   <span class="font10">high </span>
   <span class="font10">higher </span>
   <span class="font10">however, </span>
   <span class="font10">identifying </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">includes </span>
   <span class="font10">infection, </span>
   <span class="font10">infection. </span>
   <span class="font10">infection: </span>
   <span class="font10">infections, </span>
   <span class="font10">infectious </span>
   <span class="font10">infectivity </span>
   <span class="font10">information </span>
   <span class="font10">interferon-Î± </span>
   <span class="font10">intravenous </span>
   <span class="font10">investigate </span>
   <span class="font10">it's </span>
   <span class="font10">key </span>
   <span class="font10">lungs </span>
   <span class="font10">making </span>
   <span class="font10">management </span>
   <span class="font10">market </span>
   <span class="font10">mechanisms </span>
   <span class="font10">monoclonal </span>
   <span class="font10">non-structural </span>
   <span class="font10">nsp </span>
   <span class="font10">nuclear </span>
   <span class="font10">open-label, </span>
   <span class="font10">origin </span>
   <span class="font10">palm </span>
   <span class="font10">particular </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">performed </span>
   <span class="font10">pharmacodynamic </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">placebo </span>
   <span class="font10">play </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">proliferation </span>
   <span class="font10">protein. </span>
   <span class="font10">proteins. </span>
   <span class="font10">pt;} </span>
   <span class="font10">reaction </span>
   <span class="font10">released </span>
   <span class="font10">resource </span>
   <span class="font10">respect </span>
   <span class="font10">response </span>
   <span class="font10">responses </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">route, </span>
   <span class="font10">seafood </span>
   <span class="font10">secretion </span>
   <span class="font10">shows </span>
   <span class="font10">study, </span>
   <span class="font10">successfully </span>
   <span class="font10">symptomatic </span>
   <span class="font10">symptoms </span>
   <span class="font10">tablets </span>
   <span class="font10">taken </span>
   <span class="font10">tested </span>
   <span class="font10">times </span>
   <span class="font10">total </span>
   <span class="font10">triphosphate </span>
   <span class="font10">uses </span>
   <span class="font10">virological </span>
   <span class="font10">volume </span>
   <span class="font10">widely </span>
   <span class="font10">zinc </span>
  </p>
 </body>
</html>
